Bronchiectasis

This book will be published in March 2026. It will be available to pre-order in January 2026.

Edited by James Chalmers, Amelia Shoemark and Stefano Aliberti

Contents list (subject to change)
1. Patient perspective
2. Epidemiology of bronchiectasis
3. The basics of bronchiectasis
4. Radiology of bronchiectasis
5. The immunology of bronchiectasis
6. Mucociliary clearance
7. Chronic airway infection and the microbiome
8. Primary ciliary dyskinesia
9. Allergic bronchopulmonary aspergillosis
10. Autoimmune conditions and bronchiectasis
11. COPD, asthma and bronchiectasis overlap
12. Non-tuberculous mycobacterial infections and bronchiectasis
13. Bronchiectasis and immunodeficiency disorders
14. Persistent bacterial bronchitis and "pre-bronchiectasis"
15. Principles of management: an overview of the ERS Guidelines
16. Airway clearance management (including mucoactive drugs)
17. Antibiotic management – macrolides and inhaled antibiotics
18. Dipeptidyl peptidase-1 inhibitors in the management of bronchiectasis
19. Investigation and management of the "deteriorating patient"
20. Acute exacerbations of bronchiectasis
21. Bronchiectasis in children
22. Bronchiectasis clinical trial design considerations
23. The bronchiectasis treatment pipeline
24. What have we learned from the EMBARC project?
25. Research recommendations 2026–2031

Print ISBN: 978-1-84984-199-3
eISBN: 978-1-84984-200-6
EPUB ISBN: 978-1-84984-201-3